CENTESSA PHARMACEUTICALS (260) — Net Asset Momentum
CENTESSA PHARMACEUTICALS (260) recorded a net asset momentum of 31.2% as of December 2025, with net assets of €526.86 Million EUR. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. For live market cap and overall valuation, see CENTESSA PHARMACEUTICALS stock valuation.
YoY Momentum
Current Net Assets
Years of Data
Country
CENTESSA PHARMACEUTICALS Net Asset Momentum (2021–2025)
This chart tracks CENTESSA PHARMACEUTICALS's year-over-year net asset growth across 5 annual reporting periods from 2021 to 2025. The most recent momentum reading is +31.2%, with net assets of €526.86 Million EUR as of December 2025. Check how strategically is CENTESSA PHARMACEUTICALS's equity deployed to assess the company's strategic physical and investment asset allocation.
Annual Net Asset History for CENTESSA PHARMACEUTICALS (2021–2025)
The table below shows the complete annual net asset history for CENTESSA PHARMACEUTICALS from 2021 to 2025, covering 5 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. Check how tangible is CENTESSA PHARMACEUTICALS's equity to evaluate the tangible quality of the company's equity base.
| Year | Net Assets (EUR) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2025 | €526.86 Million | €687.50 Million | €160.63 Million | ▲ +31.2% |
| 2024 | €401.55 Million | €576.80 Million | €175.25 Million | ▲ +70.0% |
| 2023 | €236.24 Million | €360.25 Million | €124.00 Million | ▼ -29.7% |
| 2022 | €336.17 Million | €444.31 Million | €108.14 Million | ▼ -31.6% |
| 2021 | €491.55 Million | €629.63 Million | €138.08 Million | — |